Lamberto Andreotti

Type: Person

Name: Lamberto Andreotti

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Bristol-Myers Squibb reports lower Q1 net earnings, provides outlook for 2013

Bristol-Myers Squibb Company, a biopharmaceutical company, has reported that net earnings attributable to the company for the first quarter ended March 31, 2013 was $609 million, or $0.37 per diluted share, compared to $1.10 billion, or $0.64 per diluted ... [Published Individual.com - May 07 2013]

Entities: Bristol-Myers Squibb Company, Net Earnings, Lamberto Andreotti, Byetta

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Bristol-Myers Squibb Company

Bristol net plunges 45 pct. on generic competition

Drugmaker Bristol-Myers Squibb Co. on Thursday posted a 45 percent drop in first-quarter profit as reduced spending and a sharply lower tax rate couldn't make up for plunging sales from increased generic competition to blood thinner Plavix.Revenue from ... [Published Equities.com - Apr 25 2013]

Entities: Bristol-Myers Squibb Company, Avalide, Plavix

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Bristol-Myers Squibb Co. (BMY) Reports In-Line Q1 EPS; Reaffirms

Bristol-Myers Squibb Co. (NYSE: BMY) reported Q1 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the quarter came in at $3.83 billion versus the consensus estimate of $3.88 billion."The first quarter was a good start to an important ... [Published Street Insider - Apr 25 2013]

Entities: Bristol-Myers Squibb Company, Lamberto Andreotti, BYDUREON, Byetta, ELIQUIS

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

America’s Top 15 Most Highly Paid Pharmaceutical Industry CEOs of 2012

Here is a list of America’s Top 15 most highly paid CEOs in the pharmaceutical industry in 2012, drawn from this Forbes list of CEO pay . The figures are for 1-year pay. John H Hammergren – McKesson – $131.19 million George Paz – Express Scripts – $51.52 ... [Published Terrapinn - Apr 23 2013]

Entities: Kevin W. Sharer, Ian C Read, Robert L Parkinson, Leonard Bell

First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Bristol-Myers appoints executive vice president and chief scientific officer

Bristol-Myers Squibb Company has appointed Francis Cuss as executive vice president and chief scientific officer, effective July 1, 2013, after Elliott Sigal retires. Dr Sigal has served as the company's chief scientific officer since 2004 and on the ... [Published Individual.com - Apr 17 2013]

Entities: Bristol-Myers Squibb Company, Elliott Sigal, Appointed, Research & Development, Drug Discovery

First reported Jan 31 2013 - Updated Jan 31 2013 - 1 reports

Bristol-Myers Squibb's revenue falls by 23% on patent expiration

Bristol-Myers Squibb has suffered heavy setback during the fourth quarter ended December 2012 and its revenue declined sharply by 23.2 per cent to $ 4,191 million from $ 5,454 million in the corresponding period of last year following the US patent expiration ... [Published PharmaBiz - Jan 31 2013]

Entities: Bristol-Myers Squibb Company, Avapro, Declination

More Content

sort by: Date \| Relevance
ObamaCare Developments Could Have Major Impact ... [Published National Center for Public Policy Research - May 08 2013]
Bristol-Myers Squibb reports lower Q1 net earni... [Published Individual.com - May 07 2013]
Bristol-Myers Squibb's Management Discusses Q1 ... [Published Seeking Alpha - Apr 26 2013]
Bristol net plunges 45 pct. on generic competition [Published Equities.com - Apr 25 2013]
Bristol-Myers Squibb Earnings: Here’s Why Inves... [Published Wall St. Cheat Sheet - Apr 25 2013]
Bristol-Myers Squibb Co. (BMY) Reports In-Line ... [Published Street Insider - Apr 25 2013]
America’s Top 15 Most Highly Paid Pharmaceutica... [Published Terrapinn - Apr 23 2013]
Bristol-Myers appoints executive vice president... [Published Individual.com - Apr 17 2013]
Bristol-Myers Squibb Announces Appointment of F... [Published Yahoo! Finance - Apr 07 2013]
Bristol-Myers Squibb's revenue falls by 23% on ... [Published PharmaBiz - Jan 31 2013]
Bristol-Myers Squibb Company Earnings Call Insi... [Published Wall St. Cheat Sheet - Jan 26 2013]
Bristol Myers Squibb's CEO Discusses Q4 2012 Re... [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 24 2013]
Bristol-Myers Squibb Earnings: Here’s Why Inves... [Published Wall St. Cheat Sheet - Jan 24 2013]
Eliquis approved in US to reduce risk of stroke... [Published PharmaBiz - Jan 03 2013]
World AIDS Day: Kenneth Cole Joins Group of CEO... [Published theCSRfeed - Nov 28 2012]
European Commission approves Eliquis for preven... [Published PharmaBiz - Nov 22 2012]
AstraZeneca & BMS completes acquisition of Amyl... [Published PharmaBiz - Aug 10 2012]